Equasens Société anonyme Management
Management criteria checks 3/4
Equasens Société anonyme's CEO is Denis Supplisson, appointed in Apr 2022, has a tenure of 2.08 years. total yearly compensation is €400.20K, comprised of 44.1% salary and 55.9% bonuses, including company stock and options. directly owns 0% of the company’s shares, worth €586.15. The average tenure of the management team and the board of directors is 1.3 years and 12.4 years respectively.
Key information
Denis Supplisson
Chief executive officer
€400.2k
Total compensation
| CEO salary percentage | 44.1% |
| CEO tenure | 2.1yrs |
| CEO ownership | 0.00007% |
| Management average tenure | 1.3yrs |
| Board average tenure | 12.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | €48m |
| Mar 31 2023 | n/a | n/a | €47m |
| Dec 31 2022 | €400k | €176k | €46m |
| Jun 30 2022 | n/a | n/a | €42m |
| Mar 31 2022 | n/a | n/a | €41m |
| Dec 31 2021 | €353k | €133k | €39m |
| Sep 30 2021 | n/a | n/a | €37m |
| Jun 30 2021 | n/a | n/a | €35m |
| Mar 31 2021 | n/a | n/a | €33m |
| Dec 31 2020 | €371k | €133k | €31m |
| Sep 30 2020 | n/a | n/a | €29m |
| Jun 30 2020 | n/a | n/a | €27m |
| Mar 31 2020 | n/a | n/a | €27m |
| Dec 31 2019 | €225k | €133k | €27m |
| Sep 30 2019 | n/a | n/a | €27m |
| Jun 30 2019 | n/a | n/a | €26m |
| Mar 31 2019 | n/a | n/a | €26m |
| Dec 31 2018 | €208k | €128k | €25m |
| Sep 30 2018 | n/a | n/a | €25m |
| Jun 30 2018 | n/a | n/a | €24m |
| Mar 31 2018 | n/a | n/a | €24m |
| Dec 31 2017 | €189k | €114k | €23m |
Compensation vs Market: Denis's total compensation ($USD431.16K) is below average for companies of similar size in the UK market ($USD1.32M).
Compensation vs Earnings: Denis's compensation has been consistent with company performance over the past year.
CEO
Denis Supplisson (54 yo)
2.1yrs
Tenure
€400,201
Compensation
Mr. Denis Supplisson serves as Chief Executive Officer at Pharmagest Interactive SA since April 22, 2022. He served as Deputy Managing Director/Deputy Chief Executive Officer & Manager of the Europe Pharma...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Chairman of the Board | 14.3yrs | €8.00k | 0.033% € 278.5k | |
| Chief Executive Officer & Director | 2.1yrs | €400.20k | 0.000070% € 586.1 | |
| Director | no data | €330.17k | 0.16% € 1.3m | |
| Deputy CEO | 3.8yrs | €411.35k | 0.000070% € 586.1 | |
| Group Chief Administrative & Financial Officer | 1.3yrs | no data | no data | |
| Head of Communications | less than a year | no data | no data | |
| Chief Human Resources Officer | 4.6yrs | no data | no data | |
| Head of the Medical Solutions Division | less than a year | no data | no data | |
| Head of the Pharmagest Division | less than a year | no data | no data |
1.3yrs
Average Tenure
56yo
Average Age
Experienced Management: 0R9T's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Chairman of the Board | 14.3yrs | €8.00k | 0.033% € 278.5k | |
| Chief Executive Officer & Director | 11.3yrs | €400.20k | 0.000070% € 586.1 | |
| Director | 14.9yrs | €330.17k | 0.16% € 1.3m | |
| Deputy CEO | 3.8yrs | €411.35k | 0.000070% € 586.1 | |
| Director | 22yrs | €6.91k | 0.0033% € 27.9k | |
| Director | 13.3yrs | no data | no data | |
| Director | 13.3yrs | €5.60k | 0.0027% € 23.0k | |
| Director | 12.9yrs | no data | 0.0037% € 30.6k | |
| Independent Director | 11.9yrs | €6.91k | 0.00017% € 1.4k | |
| Independent Director | 8.9yrs | €24.76k | 0.00088% € 7.4k | |
| Independent Director | 6.9yrs | €6.15k | 0.00013% € 1.1k | |
| Director | 6.9yrs | €604.00 | 0.00011% € 921.1 |
12.4yrs
Average Tenure
61yo
Average Age
Experienced Board: 0R9T's board of directors are seasoned and experienced ( 12.4 years average tenure).